Malignant endocrine neoplasm
MONDO:0021069A malignant neoplasm affecting the endocrine glands. Representative examples include thyroid gland carcinoma, parathyroid gland carcinoma, pituitary gland carcinoma, and adrenal cortex carcinoma.
Also known as: endocrine neoplasm, Endocrine tumour, cancer of endocrine gland, endocrine cancer, endocrine gland cancer, endocrine neoplasm, malignant, malignant endocrine gland neoplasm, malignant endocrine gland tumor
5472 clinical trials for this condition and its sub-types, 17 tagged with Malignant endocrine neoplasm itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Malignant endocrine neoplasm
-
Liver cancer 254 trials · 1,700 incl. sub-types
5 sub-types
- Carcinoma of liver and intrahepatic biliary tract 36 trials · 1,455 incl. sub-types Sub-types →
- Biliary tract cancer 240 trials · 614 incl. sub-types Sub-types →
- Liver sarcoma 1 trial · 10 incl. sub-types Sub-types →
- Liver lymphoma 1 trial Sub-types →
- Calcifying nested epithelial stromal tumor of the liver 0 trials
-
Neuroendocrine carcinoma 106 trials · 744 incl. sub-types
12 sub-types
- Small cell carcinoma 26 trials · 542 incl. sub-types Sub-types →
- Cutaneous neuroendocrine carcinoma 78 trials
- Medullary thyroid gland carcinoma 42 trials · 53 incl. sub-types Sub-types →
- Large cell neuroendocrine carcinoma 12 trials · 31 incl. sub-types Sub-types →
- Pancreatic endocrine carcinoma 12 trials Sub-types →
- Malignant adrenal gland pheochromocytoma 11 trials
- Liver neuroendocrine carcinoma 3 trials Sub-types →
- Thymic neuroendocrine carcinoma 3 trials Sub-types →
- Goblet cell carcinoma 2 trials
- Anal canal neuroendocrine neoplasm 1 trial Sub-types →
- Combined lung carcinoma 0 trials · 1 incl. sub-types Sub-types →
- Vulvar neuroendocrine carcinoma 0 trials Sub-types →
-
Thyroid cancer 166 trials · 328 incl. sub-types
3 sub-types
- Thyroid gland carcinoma 41 trials · 237 incl. sub-types Sub-types →
- Thyroid lymphoma 0 trials Sub-types →
- Thyroid sarcoma 0 trials Sub-types →
-
Thymus cancer 10 trials · 225 incl. sub-types
2 sub-types
- Thymus lymphoma 0 trials · 175 incl. sub-types Sub-types →
- Thymic carcinoma 41 trials · 44 incl. sub-types Sub-types →
-
Adrenal gland cancer 16 trials · 62 incl. sub-types
3 sub-types
- Adrenal carcinoma 34 trials · 52 incl. sub-types Sub-types →
- Malignant tumor of adrenal cortex 0 trials · 42 incl. sub-types Sub-types →
- Adrenal medulla cancer 0 trials · 11 incl. sub-types Sub-types →
-
Pineal gland cancer 0 trials · 19 incl. sub-types
3 sub-types
- Pineoblastoma 15 trials Sub-types →
- Malignant pineal area germ cell neoplasm 2 trials · 3 incl. sub-types Sub-types →
- Pineal gland astrocytoma 1 trial
-
Malignant tumor of parathyroid gland 2 trials · 6 incl. sub-types
1 sub-type
- Parathyroid gland carcinoma 4 trials
-
Pituitary cancer 2 trials · 4 incl. sub-types
4 sub-types
- Pituitary adenocarcinoma 3 trials Sub-types →
- Growth hormone-producing pituitary gland carcinoma 0 trials
- Pituicytoma 0 trials
- Pituitary blastoma 0 trials
-
Ovarian neuroendocrine neoplasm 0 trials · 2 incl. sub-types
2 sub-types
- Ovarian small cell carcinoma 1 trial · 2 incl. sub-types Sub-types →
- Ovarian large-cell neuroendocrine carcinoma 0 trials
-
Malignant carotid body paraganglioma 0 trials
Most studied deeper sub-types
-
New cocktail of cancer drugs tested in desperate cases
Disease control Stopped earlyThis early-phase trial tested combinations of the drugs bevacizumab and temsirolimus, sometimes with valproic acid or cetuximab, in 154 people with advanced cancers or certain non-cancerous but progressive diseases. The main goal was to find safe doses and look for any signs that…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Immune cell therapy tested for tough childhood cancers
Disease control Stopped earlyThis early-phase study tested a treatment using donated natural killer (NK) cells from cord blood, combined with chemotherapy, for children and young adults with solid tumors that returned or didn't respond to standard care. The goal was to find the safest dose and check for side…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC